Tarveda Therapeutics' Series A Round

Tarveda Therapeutics raised a round of funding on September 23, 2011.

Tarveda Therapeutics, fka Blend Therapeutics, is a biopharmaceutical company discovering and developing Pentarins as a new class of targeted anti-cancer medicines to advance the treatment of patients …

Articles about Tarveda Therapeutics' Series A Round: